Premium
Synthesis of 2‐Fluoro N 10 ‐Substituted Acridones and Their Cytotoxicity Studies in Sensitive and Resistant Cancer Cell Lines and Their DNA Intercalation Studies
Author(s) -
Mayur Yergeri C.,
Peters Godefridus J.,
Lemos Clara,
Kathmann Ietje,
Prasad Velivela V. S. Rajendra
Publication year - 2009
Publication title -
archiv der pharmazie
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.468
H-Index - 61
eISSN - 1521-4184
pISSN - 0365-6233
DOI - 10.1002/ardp.200900046
Subject(s) - cytotoxicity , chemistry , intercalation (chemistry) , cell culture , stereochemistry , acridone , biochemistry , in vitro , biology , organic chemistry , genetics
A series of 2‐fluoro N 10 ‐substituted acridone derivatives with varying alkyl side chain length with propyl, butyl substitution, and a tertiary amine group at the terminal end of the alkyl side chain were synthesized and screened against cancer cell lines SW 1573, SW 1573 2R 160 (P‐gp substrate) which are non‐small lung cancer cell lines, MCF‐7, MCF‐7/MR (BCRP substrate) are breast cancer cell lines, 2008 WT, 2008MRP1, 2008MRP2, 2008MRP3 are ovarian cancer cell lines, and human embryo kidney cell lines like HEK293, HEK293 MRP4, and HEK293 MRP5i. The propyl‐series compounds showed lipophilicity in the range of 1.93 to 4.40 and the butyl series in the range of 2.37 to 4.78. The compounds 4 , 7 , and 8 showed good cytotoxicity against the 60 human cancer cell line panel of the National Cancer Institute, USA. The compounds 14 and 15 showed a better cytotoxicity in most of the cancer cell lines compared to other compounds tested. The DNA‐binding properties of the compounds were evaluated based on their affinity or intercalation with CT‐DNA measured with absorption titration. The compound 11 bearing planar tricyclic ring linked with a butyl methylpiperazino side chain showed the highest binding affinity with a binding constant (K i ) of 10.38×10 M –1 . Evaluation of the compounds in cell lines with an overexpression of various multidrug resistance‐related protein (MRP), P‐glycoprotein (P‐gp), or Breast Cancer Resistance Protein (BCRP) showed that all compounds are not substrates for any of these transporters.